NCT00134784View on ClinicalTrials.gov

Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression

PHASE2CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Parkinson Disease
Interventions
DRUG

[123I]B-CIT SPECT imaging

To assess \[123I\]B-CIT SPECT imaging

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Institute for Neurodegenerative Disorders

OTHER

NCT00134784 - Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression | Biotech Hunter | Biotech Hunter